|
ES2312179T3
(es)
|
1996-12-06 |
2009-02-16 |
Amgen Inc. |
Terapia combinada que utiliza un inhibidor del il-1 para el tratamiento de enfermedades mediadas por el il-1.
|
|
US7488590B2
(en)
|
1998-10-23 |
2009-02-10 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
MEP42108A
(en)
|
1998-10-23 |
2011-02-10 |
Kiren Amgen Inc |
Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
|
|
US6660843B1
(en)
*
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
AT406054B
(de)
*
|
1998-11-04 |
2000-02-25 |
Andreas Bernkop-Schnuerch |
Verfahren zur verbesserung der mucoadhäsion von polymeren sowie deren herstellung und verwendung
|
|
ES2254190T3
(es)
*
|
1999-06-21 |
2006-06-16 |
Santen Pharmaceutical Co., Ltd. |
Remedios contra la artritis deformante.
|
|
JP2003505427A
(ja)
*
|
1999-07-21 |
2003-02-12 |
オメロス コーポレイション |
疼痛、炎症および軟骨分解の抑制のための溶液および方法
|
|
US6808902B1
(en)
|
1999-11-12 |
2004-10-26 |
Amgen Inc. |
Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
|
|
AU5943201A
(en)
*
|
2000-05-03 |
2001-11-12 |
Amgen Inc |
Modified peptides as therapeutic agents
|
|
US7324635B2
(en)
|
2000-05-04 |
2008-01-29 |
Telemaze Llc |
Branch calling and caller ID based call routing telephone features
|
|
EP1712239A3
(en)
*
|
2000-05-12 |
2007-08-22 |
Immunex Corporation |
Interleukin-1 inhibitors in the treatment of diseases
|
|
AU2002213441B2
(en)
|
2000-10-12 |
2006-10-26 |
Genentech, Inc. |
Reduced-viscosity concentrated protein formulations
|
|
US8703126B2
(en)
|
2000-10-12 |
2014-04-22 |
Genentech, Inc. |
Reduced-viscosity concentrated protein formulations
|
|
US7087224B2
(en)
|
2000-10-31 |
2006-08-08 |
Amgen Inc. |
Method of treating anemia by administering IL-1ra
|
|
EP2295081B1
(en)
|
2001-06-26 |
2018-10-31 |
Amgen Inc. |
Antibodies to OPGL
|
|
US6818613B2
(en)
*
|
2001-11-07 |
2004-11-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Aqueous sustained-release formulations of proteins
|
|
WO2003061626A1
(en)
*
|
2002-01-18 |
2003-07-31 |
Control Delivery Systems, Inc. |
Polymeric gel system for the controlled delivery of codrugs
|
|
JP4606161B2
(ja)
|
2002-05-21 |
2011-01-05 |
アムジエン・インコーポレーテツド |
置換複素環式化合物および使用方法
|
|
KR101317045B1
(ko)
|
2002-09-06 |
2013-10-16 |
암젠 인코포레이티드 |
치료학적 인체 항-ｉｌ-1ｒ1 모노클로날 항체
|
|
US7429378B2
(en)
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
|
US7344716B2
(en)
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
|
US8273347B2
(en)
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
|
US7553827B2
(en)
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
|
US8361467B2
(en)
*
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
|
US8895540B2
(en)
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
|
RS57852B1
(sr)
*
|
2004-04-02 |
2018-12-31 |
Swedish Orphan Biovitrum Ab Publ |
Postupci za smanjenje agregacije il-1ra
|
|
WO2006036834A2
(en)
|
2004-09-24 |
2006-04-06 |
Amgen Inc. |
MODIFIED Fc MOLECULES
|
|
CN104689460B
(zh)
*
|
2004-12-30 |
2018-03-13 |
建新公司 |
用于关节内粘弹性补充的方案
|
|
EP2664340B1
(en)
*
|
2005-06-24 |
2020-02-12 |
Duke University |
A direct drug delivery system based on thermally responsive biopolymers
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
TW200736277A
(en)
|
2005-11-14 |
2007-10-01 |
Amgen Inc |
RANKL antibody-PTH/PTHrP chimeric molecules
|
|
US7767206B2
(en)
|
2006-10-02 |
2010-08-03 |
Amgen Inc. |
Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
|
|
GB0708376D0
(en)
|
2007-05-01 |
2007-06-06 |
Alligator Bioscience Ab |
Novel polypeptides and uses thereof
|
|
CN101918018B
(zh)
|
2007-11-14 |
2012-12-05 |
再生医药有限公司 |
使用白介素-1受体拮抗剂作为骨髓保护剂的方法
|
|
US8986696B2
(en)
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
|
EP2567692B1
(en)
|
2008-02-27 |
2016-04-06 |
Biomet Biologics, LLC |
Use of a device for obtaining interleukin-1 receptor antagonist rich solutions
|
|
KR200451958Y1
(ko)
*
|
2008-10-09 |
2011-01-21 |
(주)에이치시티 |
모바일기기용 카드형 안테나장치
|
|
AU2010221156A1
(en)
|
2009-03-06 |
2011-09-22 |
Genentech, Inc. |
Antibody formulation
|
|
US20110052561A1
(en)
*
|
2009-08-27 |
2011-03-03 |
Biomet Biologics,LLC |
Osteolysis treatment
|
|
TW201117824A
(en)
|
2009-10-12 |
2011-06-01 |
Amgen Inc |
Use of IL-17 receptor a antigen binding proteins
|
|
CN101690801B
(zh)
|
2009-10-26 |
2012-08-01 |
上海交通大学 |
白细胞介素-1受体拮抗剂的用途及其药物组合物
|
|
DE202009017772U1
(de)
|
2009-12-10 |
2011-04-21 |
Orthogen Ag |
Kombinationspräparate mit Cytokin-Antagonist und Corticosteroid
|
|
MX341578B
(es)
*
|
2011-02-08 |
2016-08-25 |
Abbvie Inc |
Tratamiento de la osteoartritis y del dolor.
|
|
ES2582928T3
(es)
|
2011-02-11 |
2016-09-16 |
Swedish Orphan Biovitrum Ab (Publ) |
Composiciones farmacéuticas exentas de citrato que comprenden anakinra
|
|
WO2013016220A1
(en)
|
2011-07-22 |
2013-01-31 |
Amgen Inc. |
Il-17 receptor a is required for il-17c biology
|
|
KR20140058581A
(ko)
|
2011-09-02 |
2014-05-14 |
노보자임스 바이오파마 디케이 에이/에스 |
지연된 약물 방출용 히알루론산 함유 경구 제형
|
|
US20140271589A1
(en)
|
2013-03-15 |
2014-09-18 |
Biomet Biologics, Llc |
Treatment of collagen defects using protein solutions
|
|
US9895418B2
(en)
|
2013-03-15 |
2018-02-20 |
Biomet Biologics, Llc |
Treatment of peripheral vascular disease using protein solutions
|
|
US9758806B2
(en)
|
2013-03-15 |
2017-09-12 |
Biomet Biologics, Llc |
Acellular compositions for treating inflammatory disorders
|
|
US10143725B2
(en)
|
2013-03-15 |
2018-12-04 |
Biomet Biologics, Llc |
Treatment of pain using protein solutions
|
|
US9878011B2
(en)
|
2013-03-15 |
2018-01-30 |
Biomet Biologics, Llc |
Treatment of inflammatory respiratory disease using biological solutions
|
|
EP3054982B1
(en)
*
|
2013-10-08 |
2019-05-01 |
Ascendis Pharma A/S |
Hydrogel-linked il-1ra prodrug
|
|
WO2015191783A2
(en)
|
2014-06-10 |
2015-12-17 |
Abbvie Inc. |
Biomarkers for inflammatory disease and methods of using same
|
|
CZ309295B6
(cs)
*
|
2015-03-09 |
2022-08-10 |
Contipro A.S. |
Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
|
|
WO2018022982A1
(en)
|
2016-07-29 |
2018-02-01 |
Trustees Of Boston University |
Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development
|
|
AR111190A1
(es)
|
2017-03-22 |
2019-06-12 |
Genentech Inc |
Composiciones en hidrogel de prodrogas entrecruzadas de ácido hialurónico y métodos relacionados
|
|
JP7241782B2
(ja)
*
|
2018-06-22 |
2023-03-17 |
ザ トラスティーズ オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク |
顎関節変性疾患の治療用の持続放出性組成物およびその方法
|
|
US12403181B2
(en)
|
2018-08-13 |
2025-09-02 |
Iltoo Pharma |
Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof
|
|
WO2020112853A1
(en)
*
|
2018-11-28 |
2020-06-04 |
Genascence Corporation |
Methods and compositions for treating osteoarthritis
|
|
EP4009998B1
(en)
*
|
2019-08-08 |
2026-03-04 |
Avidence Therapeutics, Inc. |
Microsphere-based injectible celecoxib formulation
|
|
WO2023222565A1
(en)
|
2022-05-16 |
2023-11-23 |
Institut National de la Santé et de la Recherche Médicale |
Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation
|